Quick Answer

Treatment-resistant depression (TRD) is diagnosed when a person does not experience meaningful improvement after trying at least two different antidepressant medications at adequate doses and duration. It affects roughly one in three people treated for major depression. While advanced interventions like TMS and ketamine exist, many people with TRD benefit most from an intensive, immersive level of care — such as residential mental health treatment — that addresses the biological, psychological, and environmental factors that outpatient appointments alone cannot reach. SoCal Empowered is a Joint Commission–accredited residential mental health treatment program in Orange County, California, specializing in complex, difficult-to-treat conditions including treatment-resistant depression.

Why Isn’t It Working? 

You’ve done everything right. You made the appointment. You took the medication. You went to therapy. And still — the depression hasn’t lifted the way it was supposed to.

If that sounds familiar, you’re not imagining it, and you’re not alone. What you may be dealing with is treatment-resistant depression — a well-documented clinical condition that affects millions of people and requires a different kind of response than standard outpatient care.

This article explains what treatment-resistant depression is, why it happens, what the standard treatment options are, and when a higher level of care — like residential mental health treatment — may be the next right step.

What Is Treatment-Resistant Depression?

Treatment-resistant depression (TRD) is a form of major depressive disorder that does not respond adequately to standard antidepressant treatment. Most clinicians define it as a failure to achieve meaningful improvement after trying at least two different antidepressant medications, each taken at a sufficient dose for a sufficient period of time — typically six to eight weeks.

The word “resistant” can feel discouraging, even defeating. But it’s a clinical descriptor, not a verdict. It doesn’t mean that recovery isn’t possible. It means that the treatments tried so far haven’t been the right fit — and that more targeted, intensive options need to be explored.

According to the National Institute of Mental Health, major depressive disorder is one of the most common mental health conditions in the United States, affecting more than 21 million adults. Of those treated with antidepressants, research consistently shows that roughly one third do not achieve full remission on their first or second medication trial. That’s a significant portion of people who need something more.

Why Does Depression Become Treatment-Resistant?

There is no single explanation, and that’s part of what makes TRD so challenging. Several factors — biological, psychological, and situational — can contribute:

    • Neurobiological complexity. Depression is not a single disease. Different people experience it through different neurobiological pathways, and not all antidepressants work the same way for all brains. What works for one person may be ineffective for another because of differences in how the brain processes serotonin, dopamine, or norepinephrine.
    • Genetic factors. Variations in how the body metabolizes medications can mean that standard doses either don’t reach therapeutic levels or produce side effects that prevent adequate trials. Pharmacogenomic testing — which examines how your genes affect drug response — is increasingly used to guide medication selection.
    • Unaddressed underlying conditions. Sometimes depression appears treatment-resistant because an underlying diagnosis — such as bipolar disorder, PTSD, OCD, or an anxiety disorder — has not been fully identified or treated. Treating depression alone when another condition is driving it will always fall short.
    • Psychosocial stressors. Chronic stress, trauma, unstable living situations, or relationship patterns can perpetuate depression in ways that medication alone cannot resolve. If the environment that feeds the depression is never addressed, symptom relief remains partial at best.
    • Inadequate treatment trials. Not all “failed” antidepressant trials are true failures. Sometimes medications weren’t taken at adequate doses, weren’t taken long enough, or weren’t combined with meaningful psychotherapy. A thorough clinical evaluation can help distinguish genuine TRD from an under-treated episode. In our experience, a surprising number of people who arrive presenting as treatment-resistant depression turn out to have had inadequate trials rather than true resistance. Doses that were too low, medications discontinued too early due to side effects before alternatives were tried, or therapy that was intermittent rather than consistent. A thorough intake evaluation often reveals a clearer path forward than the history suggests.

How Is Treatment-Resistant Depression Treated?

For people who haven’t responded to first- or second-line antidepressants, several additional approaches exist. The American Psychiatric Association recognizes a range of evidence-based interventions for difficult-to-treat depression:

Medication Augmentation and Adjustment

Rather than simply switching antidepressants, clinicians may add a second medication — such as an atypical antipsychotic, a mood stabilizer, or lithium — to the current regimen to enhance its effect. This approach, called augmentation, has strong evidence behind it for TRD.

Transcranial Magnetic Stimulation (TMS)

TMS is a non-invasive brain stimulation technique that uses magnetic pulses to activate specific areas of the brain associated with mood regulation. It’s FDA-cleared for treatment-resistant depression and typically administered over several weeks in an outpatient setting. It doesn’t require anesthesia or cause cognitive side effects like ECT.

Ketamine and Esketamine (Spravato)

Ketamine works on the glutamate system — a different neurological pathway than most antidepressants — and can produce rapid improvements in depressive symptoms, sometimes within hours. Esketamine (brand name Spravato) is an FDA-approved nasal spray form of ketamine specifically indicated for TRD, administered in a supervised clinical setting.

Electroconvulsive Therapy (ECT)

ECT remains one of the most effective treatments for severe, treatment-resistant depression. Despite its outdated cultural reputation, modern ECT is performed under general anesthesia and has a strong clinical evidence base for cases where other treatments have failed.

Intensive Psychotherapy

Medication adjustments rarely succeed in isolation. Intensive, evidence-based psychotherapy — including Cognitive Behavioral Therapy (CBT) — addresses the thought patterns, behavioral habits, and trauma histories that can sustain depression even when medications begin to work. For many people with TRD, the missing piece is not a different pill but a more immersive therapeutic experience.

When Outpatient Isn’t Enough: The Case for Residential Care

Outpatient treatment — weekly therapy sessions, monthly psychiatry appointments — is appropriate for many people with depression. But it has structural limitations that become significant when depression is persistent and severe.

A 50-minute therapy session once a week is 50 minutes out of 10,080 minutes. The other 10,030 minutes happen at home, in relationships, under the weight of whatever daily stressors exist. For someone with treatment-resistant depression, that ratio isn’t always sufficient.

Residential mental health treatment changes the equation. By removing a person from their day-to-day environment and placing them in a structured, therapeutically intensive setting, residential care allows for:

    • Comprehensive psychiatric evaluation. A deeper clinical review of diagnosis, medication history, and comorbid conditions — often revealing factors that were missed or underweighted in outpatient care.
    • Daily therapeutic programming. Multiple individual and group therapy sessions each week, rather than one. Evidence-based modalities like CBT, DBT, and trauma-focused approaches delivered consistently, not intermittently.
    • Medication management in real time. Adjustments can be made and monitored closely, with clinical staff available to observe response and intervene — a level of oversight that once-a-month psychiatry simply cannot replicate.
    • Environmental stabilization. For many people, the environment at home is part of what sustains depression. Residential care provides a structured, low-stress setting where therapeutic work can take hold without constant interference from outside stressors.
    • Holistic support. Nutrition, sleep, physical activity, and community — all of which have meaningful effects on mood — are integrated into daily life rather than left to chance.

This is especially relevant for people with treatment-resistant depression who are not dual-diagnosis — that is, people whose primary challenge is a mental health condition rather than substance use. Many residential programs are built around dual-diagnosis care. SoCal Empowered is not. Our program is designed exclusively for adults managing complex mental health conditions, and that focus matters when treatment resistance is the challenge.

This distinction matters more than people expect. When we work exclusively with mental health conditions — not alongside substance use treatment — our clinical team can focus entirely on the complexity of the depression itself: the diagnostic nuance, the medication history, the co-occurring conditions that may be driving the resistance. That focus changes the quality of care in ways that are hard to quantify but easy to feel.

Who Is Residential Care Right For?

Not everyone with treatment-resistant depression needs residential treatment. But several signs suggest that a higher level of care deserves serious consideration:

    • Two or more antidepressant trials without meaningful improvement
    • Persistent or worsening symptoms despite active outpatient treatment
    • Difficulty functioning at work, in relationships, or with basic daily responsibilities
    • Passive suicidal ideation or a declining sense of hope
    • A pattern of partial improvement followed by relapse
    • Comorbid anxiety, trauma, or mood instability that complicates treatment
    • An inability to engage meaningfully in outpatient therapy due to severity of symptoms

We’ve worked with clients who had tried six or seven antidepressants, had prior psychiatric hospitalizations, and arrived convinced that nothing would work. In many of those cases, what they needed wasn’t a new medication — it was a full reassessment of what was actually going on: a missed diagnosis, an unresolved trauma history, a home environment that was quietly sustaining the depression. Residential care creates the space to find that.

If you recognize yourself in that list — or if someone you love does — it doesn’t mean all hope is lost. It means the current level of care may not match the level of the problem. Residential treatment isn’t a last resort. For many people, it’s the first time they’ve received the full attention their condition has always required.

What to Look for in a Residential Program for TRD

If you’re evaluating residential programs, a few criteria matter especially when treatment resistance is the issue:

    • Specialized psychiatric expertise. Look for programs with experienced psychiatrists and clinical staff who understand the complexity of TRD — not just general depression management.
    • Individualized treatment planning. A program that assigns every patient the same protocol regardless of history is not equipped to handle the nuanced needs of someone with TRD. Ask how they approach patients who haven’t responded to prior treatments.
    • Diagnostic depth. Programs that conduct thorough assessments — including review of previous diagnoses, medications, and therapy history — are more likely to identify what’s been missed.
    • Low patient-to-staff ratios. Boutique or smaller-scale programs typically offer more individualized attention than large facilities. This matters when clinical complexity is high.
    • Accreditation. Joint Commission accreditation is the gold standard in behavioral health. It signals that a program meets rigorous national standards for safety, quality, and clinical practice.

SoCal Empowered’s residential mental health program meets all of these criteria. We’re a Joint Commission–accredited, boutique residential program in Orange County, California, with locations in Lake Forest and Mission Viejo. We treat adults managing conditions including depression, anxiety, bipolar disorder, PTSD, OCD, and related conditions — with individualized programming, low patient-to-staff ratios, and a clinical team experienced in complex, difficult-to-treat presentations.

Typical stays are 30 to 45 days. We work with most major PPO insurance plans and offer free, confidential benefits verification through our admissions team. We also work with patients whose prior authorizations have been denied — our team is experienced in the insurance navigation process and will advocate on your behalf.

You’ve Already Tried. Let’s Find What Works.

If outpatient care hasn’t been enough, residential treatment may be the level of support your depression actually requires. SoCal Empowered specializes in complex mental health conditions — no substance use treatment, no large institutional setting. Just focused, evidence-based residential care in Orange County.

Contact us today for a free evaluation and if there’s a potential fit, a free insurance evaluation to determine your coverage.

Frequently Asked Questions

What qualifies as treatment-resistant depression?

Treatment-resistant depression (TRD) is generally defined as major depression that has not responded adequately to at least two antidepressant medications, each taken at a proper dose for a sufficient duration — typically six to eight weeks. If you have tried multiple medications without meaningful improvement, a clinician may classify your depression as treatment-resistant and recommend a more intensive level of evaluation and care.

Is treatment-resistant depression curable?

Many people with treatment-resistant depression do achieve remission — but it often requires a more comprehensive and individualized approach than standard outpatient treatment. The goal is not simply to find a medication that ‘works’ but to address the full clinical picture: underlying diagnoses, therapy, environment, lifestyle, and the appropriate level of care intensity. Residential treatment has helped many people with TRD reach stability when outpatient approaches had not.

How is treatment-resistant depression different from regular depression?

All depression exists on a spectrum of severity and complexity. Treatment-resistant depression is distinguished by its failure to respond to standard first- and second-line antidepressant treatments. It often involves more complex neurobiological, psychological, or situational factors that require more targeted clinical attention. People with TRD may benefit from specialized medication strategies, intensive psychotherapy, or residential care rather than standard outpatient management.

Can residential treatment help with treatment-resistant depression?

Yes. Residential treatment is particularly well-suited for treatment-resistant depression because it provides the level of clinical intensity that outpatient care often cannot. With daily therapeutic programming, close psychiatric monitoring, medication management, and a structured therapeutic environment, residential care creates the conditions for genuine progress in people whose depression has not responded to standard approaches.

Does insurance cover residential treatment for depression?

Most PPO insurance plans cover residential mental health treatment, including for conditions like treatment-resistant depression. Federal mental health parity law requires that insurers cover mental health treatment on terms comparable to medical or surgical care. SoCal Empowered accepts most major PPO plans and provides free, confidential insurance verification before admission. Call (888) 630-3860 or visit socalempowered.com/admissions/ to check your benefits.

What happens during residential mental health treatment?

Residential mental health treatment is a structured, immersive program where adults live on-site at a licensed facility and receive daily therapeutic care. At SoCal Empowered, this includes individual therapy, group therapy, psychiatric evaluation and medication management, case management, and holistic programming — all delivered within a supportive residential setting. Typical stays are 30 to 45 days.

How do I know if I need residential treatment versus outpatient therapy?

If your symptoms are severe enough to affect your ability to function at work or in relationships, if you have tried multiple treatments without meaningful improvement, or if you are experiencing passive suicidal thoughts or a persistent loss of hope, residential treatment may provide the level of care your condition requires. A confidential evaluation with SoCal Empowered’s admissions team can help clarify the appropriate level of care for your specific situation.

Does SoCal Empowered treat substance use along with depression?

No. SoCal Empowered is a pure mental health residential program and does not treat substance use disorders. This focus is intentional — it allows us to specialize in complex mental health conditions, including treatment-resistant depression, anxiety, bipolar disorder, PTSD, and OCD, without the dual-focus of a combined rehab program. If your depression occurs alongside a substance use disorder, we can help you identify an appropriate dual-diagnosis program.

SoCal Empowered is a Joint Commission–accredited residential mental health treatment program serving adults in Orange County, California, with locations in Lake Forest and Mission Viejo.

Treatment-Resistant Depression: When Outpatient Care Isn’t Enough

May 12, 2026

Uncategorized

Written by: Dr. Sanjai Thankachen, MD

Quick Answer

Treatment-resistant depression (TRD) is diagnosed when a person does not experience meaningful improvement after trying at least two different antidepressant medications at adequate doses and duration. It affects roughly one in three people treated for major depression. While advanced interventions like TMS and ketamine exist, many people with TRD benefit most from an intensive, immersive level of care — such as residential mental health treatment — that addresses the biological, psychological, and environmental factors that outpatient appointments alone cannot reach. SoCal Empowered is a Joint Commission–accredited residential mental health treatment program in Orange County, California, specializing in complex, difficult-to-treat conditions including treatment-resistant depression.

Why Isn't It Working? 

You’ve done everything right. You made the appointment. You took the medication. You went to therapy. And still — the depression hasn’t lifted the way it was supposed to.

If that sounds familiar, you’re not imagining it, and you’re not alone. What you may be dealing with is treatment-resistant depression — a well-documented clinical condition that affects millions of people and requires a different kind of response than standard outpatient care.

This article explains what treatment-resistant depression is, why it happens, what the standard treatment options are, and when a higher level of care — like residential mental health treatment — may be the next right step.

What Is Treatment-Resistant Depression?

Treatment-resistant depression (TRD) is a form of major depressive disorder that does not respond adequately to standard antidepressant treatment. Most clinicians define it as a failure to achieve meaningful improvement after trying at least two different antidepressant medications, each taken at a sufficient dose for a sufficient period of time — typically six to eight weeks.

The word “resistant” can feel discouraging, even defeating. But it’s a clinical descriptor, not a verdict. It doesn’t mean that recovery isn’t possible. It means that the treatments tried so far haven’t been the right fit — and that more targeted, intensive options need to be explored.

According to the National Institute of Mental Health, major depressive disorder is one of the most common mental health conditions in the United States, affecting more than 21 million adults. Of those treated with antidepressants, research consistently shows that roughly one third do not achieve full remission on their first or second medication trial. That’s a significant portion of people who need something more.

Why Does Depression Become Treatment-Resistant?

There is no single explanation, and that’s part of what makes TRD so challenging. Several factors — biological, psychological, and situational — can contribute:

    • Neurobiological complexity. Depression is not a single disease. Different people experience it through different neurobiological pathways, and not all antidepressants work the same way for all brains. What works for one person may be ineffective for another because of differences in how the brain processes serotonin, dopamine, or norepinephrine.

    • Genetic factors. Variations in how the body metabolizes medications can mean that standard doses either don’t reach therapeutic levels or produce side effects that prevent adequate trials. Pharmacogenomic testing — which examines how your genes affect drug response — is increasingly used to guide medication selection.

    • Unaddressed underlying conditions. Sometimes depression appears treatment-resistant because an underlying diagnosis — such as bipolar disorder, PTSD, OCD, or an anxiety disorder — has not been fully identified or treated. Treating depression alone when another condition is driving it will always fall short.

    • Psychosocial stressors. Chronic stress, trauma, unstable living situations, or relationship patterns can perpetuate depression in ways that medication alone cannot resolve. If the environment that feeds the depression is never addressed, symptom relief remains partial at best.

    • Inadequate treatment trials. Not all “failed” antidepressant trials are true failures. Sometimes medications weren’t taken at adequate doses, weren’t taken long enough, or weren’t combined with meaningful psychotherapy. A thorough clinical evaluation can help distinguish genuine TRD from an under-treated episode. In our experience, a surprising number of people who arrive presenting as treatment-resistant depression turn out to have had inadequate trials rather than true resistance. Doses that were too low, medications discontinued too early due to side effects before alternatives were tried, or therapy that was intermittent rather than consistent. A thorough intake evaluation often reveals a clearer path forward than the history suggests.

How Is Treatment-Resistant Depression Treated?

For people who haven’t responded to first- or second-line antidepressants, several additional approaches exist. The American Psychiatric Association recognizes a range of evidence-based interventions for difficult-to-treat depression:

Medication Augmentation and Adjustment

Rather than simply switching antidepressants, clinicians may add a second medication — such as an atypical antipsychotic, a mood stabilizer, or lithium — to the current regimen to enhance its effect. This approach, called augmentation, has strong evidence behind it for TRD.

Transcranial Magnetic Stimulation (TMS)

TMS is a non-invasive brain stimulation technique that uses magnetic pulses to activate specific areas of the brain associated with mood regulation. It’s FDA-cleared for treatment-resistant depression and typically administered over several weeks in an outpatient setting. It doesn’t require anesthesia or cause cognitive side effects like ECT.

Ketamine and Esketamine (Spravato)

Ketamine works on the glutamate system — a different neurological pathway than most antidepressants — and can produce rapid improvements in depressive symptoms, sometimes within hours. Esketamine (brand name Spravato) is an FDA-approved nasal spray form of ketamine specifically indicated for TRD, administered in a supervised clinical setting.

Electroconvulsive Therapy (ECT)

ECT remains one of the most effective treatments for severe, treatment-resistant depression. Despite its outdated cultural reputation, modern ECT is performed under general anesthesia and has a strong clinical evidence base for cases where other treatments have failed.

Intensive Psychotherapy

Medication adjustments rarely succeed in isolation. Intensive, evidence-based psychotherapy — including Cognitive Behavioral Therapy (CBT) — addresses the thought patterns, behavioral habits, and trauma histories that can sustain depression even when medications begin to work. For many people with TRD, the missing piece is not a different pill but a more immersive therapeutic experience.

When Outpatient Isn’t Enough: The Case for Residential Care

Outpatient treatment — weekly therapy sessions, monthly psychiatry appointments — is appropriate for many people with depression. But it has structural limitations that become significant when depression is persistent and severe.

A 50-minute therapy session once a week is 50 minutes out of 10,080 minutes. The other 10,030 minutes happen at home, in relationships, under the weight of whatever daily stressors exist. For someone with treatment-resistant depression, that ratio isn’t always sufficient.

Residential mental health treatment changes the equation. By removing a person from their day-to-day environment and placing them in a structured, therapeutically intensive setting, residential care allows for:

    • Comprehensive psychiatric evaluation. A deeper clinical review of diagnosis, medication history, and comorbid conditions — often revealing factors that were missed or underweighted in outpatient care.

    • Daily therapeutic programming. Multiple individual and group therapy sessions each week, rather than one. Evidence-based modalities like CBT, DBT, and trauma-focused approaches delivered consistently, not intermittently.

    • Medication management in real time. Adjustments can be made and monitored closely, with clinical staff available to observe response and intervene — a level of oversight that once-a-month psychiatry simply cannot replicate.

    • Environmental stabilization. For many people, the environment at home is part of what sustains depression. Residential care provides a structured, low-stress setting where therapeutic work can take hold without constant interference from outside stressors.

    • Holistic support. Nutrition, sleep, physical activity, and community — all of which have meaningful effects on mood — are integrated into daily life rather than left to chance.

This is especially relevant for people with treatment-resistant depression who are not dual-diagnosis — that is, people whose primary challenge is a mental health condition rather than substance use. Many residential programs are built around dual-diagnosis care. SoCal Empowered is not. Our program is designed exclusively for adults managing complex mental health conditions, and that focus matters when treatment resistance is the challenge.

This distinction matters more than people expect. When we work exclusively with mental health conditions — not alongside substance use treatment — our clinical team can focus entirely on the complexity of the depression itself: the diagnostic nuance, the medication history, the co-occurring conditions that may be driving the resistance. That focus changes the quality of care in ways that are hard to quantify but easy to feel.

Who Is Residential Care Right For?

Not everyone with treatment-resistant depression needs residential treatment. But several signs suggest that a higher level of care deserves serious consideration:

    • Two or more antidepressant trials without meaningful improvement

    • Persistent or worsening symptoms despite active outpatient treatment

    • Difficulty functioning at work, in relationships, or with basic daily responsibilities

    • Passive suicidal ideation or a declining sense of hope

    • A pattern of partial improvement followed by relapse

    • Comorbid anxiety, trauma, or mood instability that complicates treatment

    • An inability to engage meaningfully in outpatient therapy due to severity of symptoms

We've worked with clients who had tried six or seven antidepressants, had prior psychiatric hospitalizations, and arrived convinced that nothing would work. In many of those cases, what they needed wasn't a new medication — it was a full reassessment of what was actually going on: a missed diagnosis, an unresolved trauma history, a home environment that was quietly sustaining the depression. Residential care creates the space to find that.

If you recognize yourself in that list — or if someone you love does — it doesn’t mean all hope is lost. It means the current level of care may not match the level of the problem. Residential treatment isn’t a last resort. For many people, it’s the first time they’ve received the full attention their condition has always required.

What to Look for in a Residential Program for TRD

If you’re evaluating residential programs, a few criteria matter especially when treatment resistance is the issue:

    • Specialized psychiatric expertise. Look for programs with experienced psychiatrists and clinical staff who understand the complexity of TRD — not just general depression management.

    • Individualized treatment planning. A program that assigns every patient the same protocol regardless of history is not equipped to handle the nuanced needs of someone with TRD. Ask how they approach patients who haven’t responded to prior treatments.

    • Diagnostic depth. Programs that conduct thorough assessments — including review of previous diagnoses, medications, and therapy history — are more likely to identify what’s been missed.

    • Low patient-to-staff ratios. Boutique or smaller-scale programs typically offer more individualized attention than large facilities. This matters when clinical complexity is high.

    • Accreditation. Joint Commission accreditation is the gold standard in behavioral health. It signals that a program meets rigorous national standards for safety, quality, and clinical practice.

SoCal Empowered’s residential mental health program meets all of these criteria. We’re a Joint Commission–accredited, boutique residential program in Orange County, California, with locations in Lake Forest and Mission Viejo. We treat adults managing conditions including depression, anxiety, bipolar disorder, PTSD, OCD, and related conditions — with individualized programming, low patient-to-staff ratios, and a clinical team experienced in complex, difficult-to-treat presentations.

Typical stays are 30 to 45 days. We work with most major PPO insurance plans and offer free, confidential benefits verification through our admissions team. We also work with patients whose prior authorizations have been denied — our team is experienced in the insurance navigation process and will advocate on your behalf.

You’ve Already Tried. Let’s Find What Works.

If outpatient care hasn’t been enough, residential treatment may be the level of support your depression actually requires. SoCal Empowered specializes in complex mental health conditions — no substance use treatment, no large institutional setting. Just focused, evidence-based residential care in Orange County.

Contact us today for a free evaluation and if there’s a potential fit, a free insurance evaluation to determine your coverage.

Frequently Asked Questions

What qualifies as treatment-resistant depression?

Treatment-resistant depression (TRD) is generally defined as major depression that has not responded adequately to at least two antidepressant medications, each taken at a proper dose for a sufficient duration — typically six to eight weeks. If you have tried multiple medications without meaningful improvement, a clinician may classify your depression as treatment-resistant and recommend a more intensive level of evaluation and care.

Is treatment-resistant depression curable?

Many people with treatment-resistant depression do achieve remission — but it often requires a more comprehensive and individualized approach than standard outpatient treatment. The goal is not simply to find a medication that ‘works’ but to address the full clinical picture: underlying diagnoses, therapy, environment, lifestyle, and the appropriate level of care intensity. Residential treatment has helped many people with TRD reach stability when outpatient approaches had not.

How is treatment-resistant depression different from regular depression?

All depression exists on a spectrum of severity and complexity. Treatment-resistant depression is distinguished by its failure to respond to standard first- and second-line antidepressant treatments. It often involves more complex neurobiological, psychological, or situational factors that require more targeted clinical attention. People with TRD may benefit from specialized medication strategies, intensive psychotherapy, or residential care rather than standard outpatient management.

Can residential treatment help with treatment-resistant depression?

Yes. Residential treatment is particularly well-suited for treatment-resistant depression because it provides the level of clinical intensity that outpatient care often cannot. With daily therapeutic programming, close psychiatric monitoring, medication management, and a structured therapeutic environment, residential care creates the conditions for genuine progress in people whose depression has not responded to standard approaches.

Does insurance cover residential treatment for depression?

Most PPO insurance plans cover residential mental health treatment, including for conditions like treatment-resistant depression. Federal mental health parity law requires that insurers cover mental health treatment on terms comparable to medical or surgical care. SoCal Empowered accepts most major PPO plans and provides free, confidential insurance verification before admission. Call (888) 630-3860 or visit socalempowered.com/admissions/ to check your benefits.

What happens during residential mental health treatment?

Residential mental health treatment is a structured, immersive program where adults live on-site at a licensed facility and receive daily therapeutic care. At SoCal Empowered, this includes individual therapy, group therapy, psychiatric evaluation and medication management, case management, and holistic programming — all delivered within a supportive residential setting. Typical stays are 30 to 45 days.

How do I know if I need residential treatment versus outpatient therapy?

If your symptoms are severe enough to affect your ability to function at work or in relationships, if you have tried multiple treatments without meaningful improvement, or if you are experiencing passive suicidal thoughts or a persistent loss of hope, residential treatment may provide the level of care your condition requires. A confidential evaluation with SoCal Empowered’s admissions team can help clarify the appropriate level of care for your specific situation.

Does SoCal Empowered treat substance use along with depression?

No. SoCal Empowered is a pure mental health residential program and does not treat substance use disorders. This focus is intentional — it allows us to specialize in complex mental health conditions, including treatment-resistant depression, anxiety, bipolar disorder, PTSD, and OCD, without the dual-focus of a combined rehab program. If your depression occurs alongside a substance use disorder, we can help you identify an appropriate dual-diagnosis program.

SoCal Empowered is a Joint Commission–accredited residential mental health treatment program serving adults in Orange County, California, with locations in Lake Forest and Mission Viejo.

Table of Contents

← Table of Contents
Scroll to Top
CALL NOW (877) 460-9609